BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32056419)

  • 21. Diagnostic utility of bronchoscopy in adults with acute myeloid leukemia and other high-grade myeloid neoplasms.
    Buckley SA; Mark NM; Othus M; Estey EH; Patel K; Walter RB
    Leuk Lymphoma; 2019 Sep; 60(9):2304-2307. PubMed ID: 30856024
    [No Abstract]   [Full Text] [Related]  

  • 22. The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Rubio MT; Labopin M; Blaise D; Socié G; Contreras RR; Chevallier P; Sanz MA; Vigouroux S; Huynh A; Shimoni A; Bulabois CE; Caminos N; López-Corral L; Nagler A; Mohty M
    Haematologica; 2015 May; 100(5):683-9. PubMed ID: 25769546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucormycosis in a patient with acute myeloblastic leukemia following liver transplantation for Wilson's disease.
    Łanocha AA; Guzicka-Kazimierczak R; Zdziarska B; Wawrzynowicz-Syczewska M
    Ann Agric Environ Med; 2019 Dec; 26(4):665-668. PubMed ID: 31885243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polycythemia following allogeneic hematopoietic progenitor cell transplantation occurring during iron chelation therapy.
    Fedele R; Cuzzola M; Irrera G; Pontari A; D'Ascola DG; Oliva EN; Martino M
    Leuk Lymphoma; 2016; 57(4):969-72. PubMed ID: 26308385
    [No Abstract]   [Full Text] [Related]  

  • 25. Concurrent Hepatic Tuberculosis and Hepatic Graft-versus-host Disease in an Allogeneic Hematopoietic Stem Cell Transplant Recipient: A Case Report.
    Zhao Z; Leow WQ
    Transplant Proc; 2017 Sep; 49(7):1659-1662. PubMed ID: 28774674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cord blood stem cell transplantation in a patient with disseminated mucormycosis and acute myelogenous leukemia.
    Aoki T; Kamezaki K; Miyamoto T; Nagafuji K; Mori Y; Yamauchi T; Takenaka K; Iwasaki H; Harada N; Shimono N; Teshima T; Akashi K
    Transpl Infect Dis; 2010 Jun; 12(3):277-9. PubMed ID: 20180927
    [No Abstract]   [Full Text] [Related]  

  • 27. [Breakthrough pulmonary mucormycosis during voriconazole treatment after reduced-intensity cord blood transplantation for a patient with acute myeloid leukemia].
    Shindo M; Sato K; Jimbo J; Hosoki T; Ikuta K; Sano A; Nishimura K; Torimoto Y; Kohgo Y
    Rinsho Ketsueki; 2007 May; 48(5):412-7. PubMed ID: 17571588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Graft-versus-host disease: have we solved the problem?
    Giralt S
    J Clin Oncol; 2012 Sep; 30(26):3160-1. PubMed ID: 22869873
    [No Abstract]   [Full Text] [Related]  

  • 29. Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trial.
    Platzbecker U; von Bonin M; Goekkurt E; Radke J; Binder M; Kiani A; Stoehlmacher J; Schetelig J; Thiede C; Ehninger G; Bornhäuser M
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):101-8. PubMed ID: 19135948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation.
    Baron F; Labopin M; Niederwieser D; Vigouroux S; Cornelissen JJ; Malm C; Vindelov LL; Blaise D; Janssen JJ; Petersen E; Socié G; Nagler A; Rocha V; Mohty M
    Leukemia; 2012 Dec; 26(12):2462-8. PubMed ID: 22699419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Human leukocyte antigen (HLA)-haploidentical hematopoietic stem cell transplantation for 8 patients with leukemia and review of the literature].
    Xie XS; Wan DM; Sun H
    Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):636-7. PubMed ID: 21122422
    [No Abstract]   [Full Text] [Related]  

  • 32. Cytomegalovirus and Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation.
    Tsao SY; Chang KC; Chen YP; Yeh YM; Su WC; Chen TY
    Ann Hematol; 2011 Jan; 90(1):113-4. PubMed ID: 20369358
    [No Abstract]   [Full Text] [Related]  

  • 33. Successful treatment of periodontal mucormycosis: report of a case and literature review.
    McDermott NE; Barrett J; Hipp J; Merino MJ; Richard Lee CC; Waterman P; Domingo DL; Walsh TJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e64-9. PubMed ID: 20219588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stem cell transplantation from a haploidentical donor versus a genoidentical sister for adult male patients with acute myelogenous leukemia in first remission: A retrospective study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation.
    Gorin NC; Labopin M; Blaise D; de Groot M; Socié G; Bourhis JH; Ciceri F; Polge E; Nagler A; Mohty M
    Cancer; 2020 Mar; 126(5):1004-1015. PubMed ID: 31774557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic hematopoietic cell transplantation with double alkylating agents containing reduced-intensity conditioning for patients ⩾60 years with advanced AML/MDS.
    Bertz H; Lübbert M; Ohneberg K; Zeiser R; Wäsch R; Marks R; Finke J
    Leukemia; 2016 Dec; 30(12):2426-2429. PubMed ID: 27573558
    [No Abstract]   [Full Text] [Related]  

  • 36. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
    Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
    Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impacts of thymoglobulin in patients with acute leukemia in remission undergoing allogeneic HSCT from different donors.
    Wakamatsu M; Terakura S; Ohashi K; Fukuda T; Ozawa Y; Kanamori H; Sawa M; Uchida N; Ota S; Matsushita A; Kanda Y; Nakamae H; Ichinohe T; Kato K; Murata M; Atsuta Y; Teshima T;
    Blood Adv; 2019 Jan; 3(2):105-115. PubMed ID: 30626574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurable residual disease, conditioning regimen intensity, and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: A registry analysis of 2292 patients by the Acute Leukemia Working Party European Society of Blood and Marrow Transplantation.
    Gilleece MH; Labopin M; Yakoub-Agha I; Volin L; Socié G; Ljungman P; Huynh A; Deconinck E; Wu D; Bourhis JH; Cahn JY; Polge E; Mohty M; Savani BN; Nagler A
    Am J Hematol; 2018 Sep; 93(9):1142-1152. PubMed ID: 29981272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vivo T-cell depletion: burden of morbidity versus survival.
    Eapen M
    Lancet Haematol; 2019 Feb; 6(2):e63-e64. PubMed ID: 30709434
    [No Abstract]   [Full Text] [Related]  

  • 40. Pre-engraftment graft-versus-host disease after allogeneic hematopoietic cell transplantation for acute leukemia.
    Lee JH; Lee JH; Kim DY; Yun SC; Kim SD; Choi Y; Lee YS; Kang YA; Jeon MJ; Seol M; Lee KH
    Eur J Haematol; 2011 Aug; 87(2):172-81. PubMed ID: 21599753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.